AzTrials
AzTrials

Lateral Patellar SyndromeNCT06988930

To Compare the Clinical Efficacy of Arthroscopic Lateral Retinacular Release and Exercise Therapy in the Treatment of Lateral Patellar Crush Syndrome

A study of Lateral Patellar Syndrome, run by Peking University Third Hospital at 1 site in China.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

One hundred patients with lateral patellar compression syndrome (LPCS) were recruited and divided into two groups: arthroscopic treatment group and rehabilitation conservative treatment group. A 2-year prospective cohort study was then conducted. Read more about this study

Who is it for?
Any age
Conditions the study is for
Lateral Patellar Syndrome
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteChina
Study dates
1 Mar 2024to 31 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • ① Meet the diagnostic criteria of LPCS; ② Complete imaging data; ③ agree that the follow-up time should be at least 1 Years; ④ Those who are willing to conduct regular rehabilitation training can cooperate to complete the experiment by signing the informed consent.

Who cannot join

  • ① Complicated with severe heart, brain, kidney and other organ dysfunction;② Combined with patellar instability, patellar dislocation or others Severe knee joint disease and injury; ③ The previous history of joint infection, joint tuberculosis or osteomyelitis, or the lower extremity in 6 A history of surgery within the last month and previous knee surgery; ④ Infection, cancer, pregnancy and mental disorders Those with special conditions. ⑤ patients with mental illness or cognitive impairment, unable to study and participate in rehabilitation training; ⑥ not Informed consent was obtained.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

China1 site
  • Peking University Third Hospital

    Beijing

Other trials in China

About this study

One hundred patients with lateral patellar compression syndrome (LPCS) were recruited and divided into two groups: arthroscopic treatment group and rehabilitation conservative treatment group. A 2-year prospective cohort study was then conducted. The subjective scores of 5 scales and 3 objective indexes were used to evaluate the recovery of knee joint function after different treatment methods, and to further clarify the medium and long-term therapeutic effects of different treatment methods on LPCS patients.

Read the detailed description

Lateral patellar over-compression syndrome is a musculoskeletal disease characterized by increased pressure on the lateral patellofemoral joint, which is caused by long-term tilting of the patella, adaptive contraction of the lateral retinaculum and long-term stress imbalance of the medial and lateral articular surfaces. The main clinical manifestations are patellofemoral joint pain, abnormal patellar trajectory and articular cartilage injury. At present, the prevalence of anterior knee pain is as high as 8. 5% ~ 17. 0%, and female is higher than male. LPCS has become one of the main causes of anterior knee pain . There are many methods for the treatment of LPCS, some of which are still controversial. At present, the gold standard for the treatment of LPCS has not been determined.

In the clinical practice of the Institute of Sports Medicine and the previous scientific research of our group, we found that a considerable number of patients, after arthroscopic patella molding, lateral retinaculum release and joint cleaning, their pain was obviously relieved, the patella trajectory almost returned to normal, and the knee joint symptoms were well improved and returned to normal life.

Both arthroscopic surgery and conservative rehabilitation can be used to treat LPCS, but it has not been proved that the functional improvement and symptom improvement rate of the two treatment methods are better in the medium and long term follow-up. Based on the above background, this study will conduct a prospective cohort study, and plan to recruit 100 patients and divide them into two groups, namely the arthroscopic group and the conservative treatment group, for a 2-year follow-up. The patients' subjective scores of 5 scales and 3 objective indicators were used to evaluate the recovery of knee function after different treatment methods, and to further clarify the medium and long-term therapeutic effects of different treatment methods on patients with LPCS, in order to provide guidance and reference for the clinical treatment of LPCS.

Being tested
Control group
Keywords
lateral patellar compression syndrome, lateral retinacular release of the patella, patellofemoral joint rehabilitation, prospective cohort study, kinesitherapy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Control groupDiagnostic test

    The non-operation group was treated with rehabilitation therapy for 6 weeks, and the operation group was treated with arthroscopic surgery and the pathological tissue of cartilage and subchondral bone was taken. Assessment was performed at three months, one year, and two years after treatment and recorded in the database.

Study groups in NCT06988930
Study groupRoleWhat they receive
Experimental group:arthroscopic surgeryExperimentalThe patients with lateral patellar extrusion were treated with arthroscopic minimally invasive surgery.
Receives: Diagnostic Test: Control group
Conservative rehabilitation training groupActive comparatorThe patients in this group were treated with exercise therapy
Receives: Diagnostic Test: Control group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patellar axial X-ray

    The degree of deviation of the patella was evaluated mainly by X-ray measurement

    Measured: Before the intervention、3 months after the intervention and 1 year after the intervention

Secondary outcomes (3)
  1. Visual Analogue Score

    The Visual Analog Scale (VAS) is a tool used to assess pain or other subjective sensations. It is typically represented by a line segment, with one end indicating no pain or symptoms and the other end indicating the most severe pain or symptoms. In clinical research, the VAS is commonly used to evaluate the level of pain experienced by patients. Patients mark their pain level on a line segment that is marked from 0 to 10 , where 0 represents no pain and 10 represents the most severe pain.

    Measured: Before the intervention、3 months after the intervention and 1 year after the intervention

  2. Kujala score

    The Kujala score is a system used to assess knee function. It quantifies pain, functional impairment, muscle strength, range of motion, swelling, and crepitus in the knee joint through a series of questions and examinations, thereby evaluating the overall condition of the knee. The score ranges from 0 to 100, with 100 being the highest possible score. A higher score indicates better knee function and less pain and functional impairment. Conversely, a lower score indicates severe knee dysfunction and significant pain and impairment. It is widely used in the diagnosis of knee-related diseases, evaluation of treatment outcomes, and rehabilitation guidance.

    Measured: Before the intervention、3 months after the intervention and 1 year after the intervention

  3. Lysholm knee score scale

    The Lysholm knee score scale is mainly used to assess the functional recovery of the knee joint after injury or surgery and can also be applied in clinical research of knee joint diseases. It focuses on the patient's subjective feelings and ability to perform daily activities.

    Measured: Before the intervention、3 months after the intervention and 1 year after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 May 2025
  2. Study start1 Mar 2024
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06988930
Sponsor's protocol ID
M2024181
Status last verified
Apr 2025
First submitted
7 Apr 2025
Last updated
25 May 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study of Lateral Patellar Syndrome, run by Peking University Third Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 25 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patellar axial X-ray (time frame: Before the intervention、3 months after the intervention and 1 year after the intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in